Hill Callum, Ah-See Kim, Moffat Helen
The University of Aberdeen, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
Ear, Nose and Throat Department, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
Clin Otolaryngol. 2025 May;50(3):500-506. doi: 10.1111/coa.14278. Epub 2025 Jan 16.
Currently, there is no adult-specific decision aid (DA) to support decision-making regarding recurrent tonsillitis. This study intends to address this gap by piloting a prototype DA.
Randomised clinical trial.
Single centre trial at a tertiary otolaryngology department.
Forty-three patients were randomised to either the DA or Treatment as Usual (TAU) group.
Primary objective: To measure how patients rate the quality of their decision-making experience at the time of the decision and at follow-up (SURE scale).
The level of decisional satisfaction at the time of the decision and follow-up, as well as to explore the numbers of people opting for surgery for each study condition (Shared tool and patient feedback).
Quality: This study demonstrates no statistically significant difference in how patients rate the quality of their treatment decision between DA and TAU, both at baseline (p = 0.553) and follow-up (p = 0.062). Satisfaction: This study showed a statistically significant level of decisional satisfaction at the time the decision was made for Qu2 of the Shared tool (U = 113, p = 0.026). No other significant difference was found between participants who received the DA and TAU.
The DA is an acceptable and useful tool that could be incorporated into the pathway for recurrent tonsillitis, helping to eliminate physician implicit bias. However, preliminary qualitative evidence from this pilot study does not suggest that including the DA improves the quality of decision-making.
IRAS ID - 230 362.
目前,尚无专门针对成人的决策辅助工具(DA)来支持有关复发性扁桃体炎的决策制定。本研究旨在通过试点一个DA原型来填补这一空白。
随机临床试验。
在一家三级耳鼻喉科进行的单中心试验。
43名患者被随机分为DA组或常规治疗(TAU)组。
主要目标:衡量患者在决策时和随访时对其决策体验质量的评分(SURE量表)。
决策时和随访时的决策满意度水平,以及探讨每种研究条件下选择手术的人数(共享工具和患者反馈)。
质量:本研究表明,在基线时(p = 0.553)和随访时(p = 0.062),患者对DA组和TAU组治疗决策质量的评分在统计学上无显著差异。满意度:本研究显示,在使用共享工具的Qu2进行决策时,决策满意度具有统计学意义(U = 113,p = 0.026)。在接受DA和TAU的参与者之间未发现其他显著差异。
DA是一种可接受且有用的工具,可纳入复发性扁桃体炎的诊疗流程,有助于消除医生的隐性偏见。然而,这项初步试点研究的定性证据并不表明使用DA能提高决策质量。
IRAS编号 - 230 362。